MEMBRANE-ANCHORED IL-12 Read more about MEMBRANE-ANCHORED IL-12 US Application 62/638,498Filed on 2018-03-05
ADAM17 BINDING MOLECULES AND USES THEREOF Read more about ADAM17 BINDING MOLECULES AND USES THEREOF US Application 62/630,877Filed on 2018-02-15
T CELL RECEPTORS WHICH TARGET KK-LC-1 Read more about T CELL RECEPTORS WHICH TARGET KK-LC-1 US Application 62/640,738Filed on 2018-03-09
17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER Read more about 17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER US Application 62/639,337Filed on 2018-03-06
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY US Application 62/628,961Filed on 2018-02-10
Nucleic Acid Nanoparticles (NANP) and Methods of Using Same for Controlled Immunomodulation Read more about Nucleic Acid Nanoparticles (NANP) and Methods of Using Same for Controlled Immunomodulation US Application 62/623,496Filed on 2018-01-29
HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS Read more about HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS US Application 62/631,390Filed on 2018-02-15
TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 Read more about TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 US Application 62/628,454Filed on 2018-02-09
Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy Read more about Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy US Application 62/572,926Filed on 2017-10-16
A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER Read more about A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER US Application 62/627,926Filed on 2018-02-08